{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:40:03Z","timestamp":1750934403528,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,26]]},"DOI":"10.7759\/cureus.86785","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:02:31Z","timestamp":1750932151000},"source":"Crossref","is-referenced-by-count":0,"title":["Aggressive Progression of High Programmed Death-Ligand 1 (PD-L1) Non-small Cell Lung Cancer Presenting as Life-Threatening Esophageal Obstruction: A Case of Food Impaction Secondary to Subcarinal Lymph Node Compression"],"prefix":"10.7759","author":[{"given":"Niroshan","family":"Ranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaman","family":"Dalati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidushan","family":"Sabanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanujan","family":"Thangadurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck M","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al.. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016, 375:1823-33. 10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/014107680109401104","article-title":"The causes of dysphagia in carcinoma of the lung","volume":"94","author":"Camidge DR","year":"2001","unstructured":"Camidge DR. The causes of dysphagia in carcinoma of the lung. J R Soc Med. 2001, 94:567-72. 10.1177\/014107680109401104","journal-title":"J R Soc Med"},{"key":"ref3","article-title":"Esophageal stricture","author":"Desai JP","year":"2023","unstructured":"Desai JP, Moustarah F. Esophageal stricture. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5152\/jarem.2015.777","article-title":"The benign strictures of the esophagus","volume":"6","author":"K\u00f6ksoy FN","year":"2016","unstructured":"K\u00f6ksoy FN, G\u00f6n\u00fcll\u00fc D. The benign strictures of the esophagus. J Acad Res Med. 2016, 6:1-4. 10.5152\/jarem.2015.777","journal-title":"J Acad Res Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101683","article-title":"Palliation of malignant esophageal obstruction using an anti-migration self-expandable metal stent: results of a prospective multicenter study","volume":"45","author":"Conio M","year":"2021","unstructured":"Conio M, Savarese MF, Filiberti RA, et al.. Palliation of malignant esophageal obstruction using an anti-migration self-expandable metal stent: results of a prospective multicenter study. Clin Res Hepatol Gastroenterol. 2021, 45:101683. 10.1016\/j.clinre.2021.101683","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.21037\/aoe.2018.03.01","article-title":"A practical guide to the management of dysphagia in patients with metastatic esophageal cancer","volume":"1","author":"Sadaps M","year":"2018","unstructured":"Sadaps M, Bhatt A, Chevalier C, Sohal D, Videtic G, McNamara MJ. A practical guide to the management of dysphagia in patients with metastatic esophageal cancer. Ann Esophagus. 2018, 1:0.","journal-title":"Ann Esophagus"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1007\/s10388-009-0194-z","article-title":"Esophageal stenosis caused by T0 lung cancer with lymph node metastasis: a case report","volume":"6","author":"Nemoto H","year":"2009","unstructured":"Nemoto H, Saito M, Hibi K. Esophageal stenosis caused by T0 lung cancer with lymph node metastasis: a case report. Esophagus. 2009, 6:197-200.","journal-title":"Esophagus"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.14309\/01.ajg.0000865844.30628.45","article-title":"Dysphagia: an unusual primary presentation of non-small cell lung cancer","volume":"117","author":"Sharma R","year":"2022","unstructured":"Sharma R, Chandler Z, Karan A, Deol T, Ribeiro B. Dysphagia: an unusual primary presentation of non-small cell lung cancer. Am J Gastroenterol. 2022, 117:e1549-50.","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00149","article-title":"Updated analysis of KEYNOTE- 024: Pembrolizumab monotherapy versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater","volume":"37","author":"Reck M","year":"2019","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, et al.. Updated analysis of KEYNOTE- 024: Pembrolizumab monotherapy versus platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater. J Clin Oncol. 2019, 37:537-46. 10.1200\/JCO.18.00149","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC","volume":"383","author":"Herbst RS","year":"2020","unstructured":"Herbst RS, Giaccone G, de Marinis F, et al.. Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC. N Engl J Med. 2020, 383:1328-39. 10.1056\/NEJMoa1917346","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei H","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, et al.. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015, 373:1627-39. 10.1056\/NEJMoa1507643","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129465","article-title":"Immunotherapy resistance in non-small-cell lung cancer: from mechanism to clinical strategies","volume":"14","author":"Zhou S","year":"2023","unstructured":"Zhou S, Yang H. Immunotherapy resistance in non-small-cell lung cancer: from mechanism to clinical strategies. Front Immunol. 2023, 14:0. 10.3389\/fimmu.2023.1129465","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma P","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell. 2017, 168:707-23. 10.1016\/j.cell.2017.01.017","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1741","article-title":"Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1","volume":"23","author":"Champiat S","year":"2017","unstructured":"Champiat S, Dercle L, Ammari S, et al.. Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1. Clin Cancer Res. 2017, 23:1920-8. 10.1158\/1078-0432.CCR-16-1741","journal-title":"Clin Cancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.3676","article-title":"Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy","volume":"4","author":"Ferrara R","year":"2018","unstructured":"Ferrara R, Mezquita L, Texier M, et al.. Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy. JAMA Oncol. 2018, 4:1543-52. 10.1001\/jamaoncol.2018.3676","journal-title":"JAMA Oncol"},{"key":"ref16","article-title":"Dynamic 18F-FDG PET\/CT imaging: quantitative assessment of tumor response to immunotherapy in non-small cell lung cancer","volume":"15","author":"Liu Y","year":"2025","unstructured":"Liu Y, Zhou H, Wang S, et al.. Dynamic 18F-FDG PET\/CT imaging: quantitative assessment of tumor response to immunotherapy in non-small cell lung cancer. Front Oncol. 2025, 15:0.","journal-title":"Front Oncol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1231094","article-title":"Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer","volume":"13","author":"Zhou R","year":"2023","unstructured":"Zhou R, Tong F, Zhang Y, et al.. Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer. Front Oncol. 2023, 13:1231094.","journal-title":"Front Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.047829","article-title":"Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes","volume":"61","author":"Herth FJ","year":"2006","unstructured":"Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006, 61:795-8. 10.1136\/thx.2005.047829","journal-title":"Thorax"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2008.03.467","article-title":"Esophageal stents for palliation of malignant dysphagia due to extrinsic compression","volume":"67","author":"Verschuur EM","year":"2008","unstructured":"Verschuur EM, Kuipers EJ, Siersema PD. Esophageal stents for palliation of malignant dysphagia due to extrinsic compression. Gastrointest Endosc. 2008, 67:pAB188-AB189.","journal-title":"Gastrointest Endosc"},{"key":"ref20","article-title":"A comprehensive review of esophageal stents","volume":"8","author":"Hindy P","year":"2012","unstructured":"Hindy P, Hong J, Lam-Tsai Y, Gress F. A comprehensive review of esophageal stents. Gastroenterol Hepatol (N Y). 2012, 8:526-34.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.6468","article-title":"Evaluation of the incidence of esophageal complications associated with balloon dilation and their management in patients with malignant esophageal strictures","volume":"198","author":"Fan Y","year":"2012","unstructured":"Fan Y, Song HY, Kim JH, et al.. Evaluation of the incidence of esophageal complications associated with balloon dilation and their management in patients with malignant esophageal strictures. AJR Am J Roentgenol. 2012, 198:213-8. 10.2214\/AJR.11.6468","journal-title":"AJR Am J Roentgenol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky JM","year":"2016","unstructured":"Zaretsky JM, Garcia-Diaz A, Shin DS, et al.. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med. 2016, 375:819-29. 10.1056\/NEJMoa1604958","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30070447","article-title":"Endoscopic stenting for malignant dysphagia in patients with esophageal cancer","volume":"30","author":"Ishihara R","year":"2023","unstructured":"Ishihara R. Endoscopic stenting for malignant dysphagia in patients with esophageal cancer. Curr Oncol. 2023, 30:5984-94. 10.3390\/curroncol30070447","journal-title":"Curr Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381968-aggressive-progression-of-high-programmed-death-ligand-1-pd-l1-non-small-cell-lung-cancer-presenting-as-life-threatening-esophageal-obstruction-a-case-of-food-impaction-secondary-to-subcarinal-lymph-node-compression","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T10:02:33Z","timestamp":1750932153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381968-aggressive-progression-of-high-programmed-death-ligand-1-pd-l1-non-small-cell-lung-cancer-presenting-as-life-threatening-esophageal-obstruction-a-case-of-food-impaction-secondary-to-subcarinal-lymph-node-compression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.86785","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}